-
REAL-WORLD EFFECTIVENESS OF TEPOTINIB MONOTHERAPY (TEPOTINIB) VERSUS PEMBROLIZUMAB ± CHEMOTHERAPY (PEMBRO±CT) IN 1L FOR PATIENTS WITH MET EXON 14 SKIPPING ALTERATIONS IN LOCALLY ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER IN THE US
Aug 11, 2026, 17:16 PM -
A MULTI-COUNTRY PAYER AND HTA EXPERT SURVEY EXAMINING HOW ACCESS DECISION-MAKERS NAVIGATE INFORMATION OVERLOAD AND EVOLVING EVIDENCE SOURCES
Aug 11, 2026, 17:16 PM -
DOES INTERNATIONAL MIGRATION SHIFT HEALTHCARE SPENDING TOWARD FORMAL CARE? EVIDENCE FROM RURAL BANGLADESH
Aug 11, 2026, 17:16 PM -
DATA ACCESSIBILITY AND METHODOLOGICAL HETEROGENEITY IN ESTIMATING THE BURDEN OF RARE DISEASES ACROSS FOUR CENTRAL AND EASTERN EUROPEAN COUNTRIES: A CROSS-COUNTRY COMPARISON
Aug 11, 2026, 17:16 PM -
EXTERNAL VALIDATION OF DIABETIC RETINOPATHY RISK PREDICTION EQUATIONS IN TAIWANESE PATIENTS WITH TYPE 2 DIABETES
Aug 11, 2026, 17:16 PM -
FOREGONE HEALTH GAINS FROM PASKWIL-NEGATIVE ONCOLOGY DRUGS IN THE PALLIATIVE SETTING: A MODEL-BASED ANALYSIS
Aug 11, 2026, 17:16 PM -
CATASTROPHIC AND IMPOVERISHING DENTAL PAYMENTS IN GREECE: EVIDENCE FROM HOUSEHOLD BUDGET SURVEY DATA
Aug 11, 2026, 17:16 PM -
MARKET-BASED PRICE COMPETITION IN THE GERMAN PATENT PHARMACEUTICAL MARKET: EVALUATING SELECTIVE CONTRACTING AS A NOVEL COST-CONTAINMENT INSTRUMENT
Aug 11, 2026, 17:16 PM -
A PROBABILISTIC FRAMEWORK FOR COMPARING THE PUBLIC HEALTH IMPACT OF ADJUVANTED RSVPREF3 AND NON-ADJUVANTED RSVPREF VACCINES IN ITALY
Aug 11, 2026, 17:16 PM -
LONGITUDINAL ADHERENCE PATTERNS OF ASCIMINIB VERSUS OTHER TYROSINE KINASE INHIBITORS IN CHRONIC MYELOID LEUKEMIA: A GROUP-BASED TRAJECTORY ANALYSIS
Aug 11, 2026, 17:16 PM -
DOES RETRIEVAL-AUGMENTED GENERATION IMPROVE ARTIFICIAL INTELLIGENCE (AI) WRITING QUALITY FOR HEALTH ECONOMICS AND OUTCOMES RESEARCH (HEOR) ENVIRONMENTS? A CONTROLLED MULTI-MODEL ASSESSMENT USING A CANADIAN HEALTH TECHNOLOGY ASSESSMENT (HTA) KNOWLEDGE...
Aug 11, 2026, 17:16 PM -
FIDELITY-BOUNDED SYNTHETIC COHORTS FOR TRIAL-DESIGN EXPLORATION: AN ENDPOINT-EFFICIENCY CASE STUDY IN PEDIATRIC RHINOPHARYNGITIS
Aug 11, 2026, 17:16 PM -
MULTIDIMENSIONAL SUFFERING DRIVING EUTHANASIA REQUESTS IN COLOMBIAN CANCER PATIENTS: A RETROSPECTIVE STUDY FROM A PIONEERING LATIN AMERICAN COUNTRY
Aug 11, 2026, 17:16 PM -
WHEN THE LABEL MOVES: MID-ASSESSMENT INDICATION CHANGES AND THE COST OF VOIDED DOSSIERS IN EU JOINT CLINICAL ASSESSMENT
Aug 11, 2026, 17:16 PM -
POTENTIAL SAVINGS FROM THE IMPLEMENTATION OF PHARMACEUTICAL COST CONTAINMENT GUIDELINES IN HOSPITALS
Aug 11, 2026, 17:16 PM -
COST-EFFECTIVENESS ANALYSIS OF THE TWENTY-VALENT PNEUMOCOCCAL CONJUGATE VACCINE AGAINST THE THIRTEEN-VALENT PNEUMOCOCCAL CONJUGATE VACCINE FOR PAEDIATRIC VACCINATIONS IN MOROCCO FROM THE PUBLIC HEALTHCARE PAYER PERSPECTIVE
Aug 11, 2026, 17:16 PM -
GLP-1S FOR TREATMENT OF TOBACCO AND ALCOHOL DEPENDENCE: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RCTS AND EXPERIMENTS
Aug 11, 2026, 17:16 PM -
EVALUATING THE ECONOMIC IMPACT AND DIAGNOSTIC EFFICIENCY OF PLASMA PTAU217 TESTING IN THE UK NHS ALZHEIMER'S DISEASE PATHWAY
Aug 11, 2026, 17:16 PM -
MISSING MEDICINES IN GI ONCOLOGY: ACCESS TO HIGH CLINICAL BENEFIT THERAPIES IN IRELAND
Aug 11, 2026, 17:16 PM -
REAL-WORLD HEALTHCARE RESOURCE UTILIZATION AND ASSOCIATED COSTS OF OCRELIZUMAB COMPARED TO OFATUMUMAB IN FRANCE: 12-MONTH RESULTS FROM THE OLIDIA COHORT
Aug 11, 2026, 17:16 PM
